|
Download these OTIS Research Studies: Bakhireva
LN, Jones KL, Schatz M, Johnson D, Chambers CD, and the Organization
of Teratology Information Services Research Group. "Asthma
Medication Use in Pregnancy and Fetal Growth." J.
Allergy Clin Immunol, 116:3, 503-9. [ Chambers
CD, Johnson DL, Macaraeg GR, Jones KL. 2004. Pregnancy
Outcome Following Early Gestational Exposure to Leflunomide: The
Otis Rheumatoid Arthritis in Pregnancy Study (104). Pharmacoepidemiology
and Drug Safety, 13: S1–S334 (2004). [ Chambers
CD, Johnson DL, Jones KL, The OTIS Collaborative Research Group.
2004. Pregnancy Outcome in Women
Exposed to Anti-TNF-alpha Medications: The OTIS Rheumatoid Arthritis
in Pregnancy Study. Arthritis and Rheumatism
50(9). [ Chambers
CD, Braddock SR, Briggs GG, Einarson A, Johnson YR, Miller RK,
Polifka JE, Robinson LK, Stepanuk K, Lyons Jones K. 2001 Postmarketing
Surveillance for Human Teratogenicity: A Model Approach. Teratology
64:252-261. [ Einarson
A, Fatoye B, Sarkar M, Lavigne S, Brochu J, Chambers C, Mastroiacovo
P, Addis A, Matsui D, Schuler L, Einarson T, Foren G. 2001. Pregnancy
Outcome Following Gestational Exposure to Venlafaxine: A Multicenter
Prospective Controlled Study. Am J Psychiatry
158:1728-1730. [ Leen-Mitchell
M, Martinez L, Gallegos S, Robertson J, Carey JC. 2000. Mini-Review:
History of Organized Teratology Information Services in North
America. Teratology 61:314-317. [ Einarson
A, Phillips E, Mawji F, D'Alimonte D, Schick B, Addis A, Mastroiacova
P, Mazzone T, Matsui D, Koren G. 1998. A
prospective controlled multicentre study of clarithromycin in
pregnancy. Am. J. Perinatol. 15:523-525.
[ Loebstein
R, Addis A, Ho E, Andreou R, Sage S, Donnenfeld AE, Schick B,
Bonati M, Moretti M, Lalkin A, Pastuszak AL, Koren G. 1998. Pregnancy
Outcome following gestational exposure to fluoroquinolones: a
multicenter prospective controlled study. Antimicrob.
Agents Chemother. 42:1336-1339. [ Shuhaiber
S, Pastuszak AL, Schick B, Matsui D, Spivey G, Brochu J, Koren
G. 1998. Pregnancy
outcome following first trimester exposure to sumatriptan.
Neurology 51:581-3. [ Bailey
B, Addis A, Lee A,Sanghvi K, Mastroiacovo P, Mazzone T, Bonati
M, Paolini C, Garbis H, Val T, DeSouza CF, Matsui D, Schechtman
AS, Conover B, Lau M, Koren G. 1997. Cisapride
use during human pregnancy: a prospective, controlled multicenter
study. Dig. Dis. Sci. 42:1848-52. [
Feldkamp
ML, Jones KL, Ornoy A, Pastuszak AL, Rosenwasser S, Schick B,
Bar J, and Tiqva P. 1997. Postmarketing
Surveillance for Angiotensin-Converting Enzyme Inhibitor Use During
the First Trimester of Pregnancy-United States, Canada and Israel.
1987-1995. MMWR 46:11:240-242. [ Pastuszak
AL, Levy M, Schick B, Zuber C, Feldkamp ML, Gladstone J, Bar-Levy
F, Jackson E, Donnenfeld A, Meschino W, Koren G. 1994. Outcome
after maternal varicella infection in the first 20 weeks of pregnancy.
N. Engl. J. Med. 330:901-905. [ Pastuszak
AL, Schick-Boschetto B, Zuber C, Feldkamp ML, Pinelli M, Sihn
S, Donnenfeld A, McCormack M, Leen-Mitchell M, Woodland C, Gardner
A, Horn G, Koren G. 1993. Pregnancy
Outcome following First-Trimester Exposure to Fluoxetine (Prozac).
JAMA 269:2246-2248. [ Jacobson
SJ, Jones K, Johnson K, Ceolin L, Kaur P, Sahn D, Donnenfeld AE,
Rieder M, Santelli R, Smythe J, et al. 1992. "Prospective
Multicentre Study of Pregnancy Outcome after Lithium Exposure
during First Trimester. Lancet 339:530-33.
[
rev. 23-June-2005 |
abstract]
abstract]